Objectives Recent evidence shows that patients using HIV pre-exposure prophylaxis (PrEP) have an increased rate of bacterial STIs, including syphilis, chlamydia and gonorrhoea. Our study aimed to describe the acquisition and the susceptibility for macrolides ofMycoplasma genitaliumin men who have sex with men (MSM) on PrEP. Methods We studied all MSM who started PrEP in the AZ Sint-Jan Hospital Bruges from 1 June 2017 to 31 March 2019 with at least one follow-up visit. Patients were screened forM. genitaliumand other STIs with pooled rectal swabs, pharyngeal swabs and first-voided urine, and blood samples at baseline and quarterly intervals after initiating PrEP. TaqMan Array Card technology was used to detectM. genitaliumand determine macr...
Objectives: Azithromycin treatment of Chlamydia trachomatis (CT) may not be adequate to treat concom...
BackgroundPre-exposure prophylaxis (PrEP) is an effective method for reducing HIV incidence among at...
ObjectivesMacrolide resistance in Mycoplasma genitalium is emerging globally. There is paucity of da...
Objectives Recent evidence shows that patients using HIV pre-exposure prophylaxis (PrEP) have an inc...
International audienceObjectives. - Limited data on Mycoplasma genitalium infection has been reporte...
International audienceObjectives: Men engaged in high-risk sexual behaviour, such as MSM, are likely...
Background Mycoplasma genitalium (Mg) is an emerging sexually transmitted pathogen among men who ...
Abstract Background: Mycoplasma genitalium (MG) is an emerging sexually transmitted pathogen and a c...
During 2016–2017, we tested asymptomatic men who have sex with men (MSM) in Melbourne, Australia, fo...
BACKGROUND Mycoplasma genitalium infection is a public health concern due to extensive antimicrob...
Abstract Background Antimicrobial resistance in Mycoplasma genitalium is rising globally with result...
During 2016-2017, we tested asymptomatic men who have sex with men (MSM) in Melbourne, Australia, fo...
BackgroundPre-exposure prophylaxis (PrEP) is an effective method for reducing HIV incidence among at...
Mycoplasma genitalium (MG) is a sexually transmitted bacterium in which macrolide resistance is rapi...
OBJECTIVES: Limited data on Mycoplasma genitalium infection has been reported among PrEP users. The ...
Objectives: Azithromycin treatment of Chlamydia trachomatis (CT) may not be adequate to treat concom...
BackgroundPre-exposure prophylaxis (PrEP) is an effective method for reducing HIV incidence among at...
ObjectivesMacrolide resistance in Mycoplasma genitalium is emerging globally. There is paucity of da...
Objectives Recent evidence shows that patients using HIV pre-exposure prophylaxis (PrEP) have an inc...
International audienceObjectives. - Limited data on Mycoplasma genitalium infection has been reporte...
International audienceObjectives: Men engaged in high-risk sexual behaviour, such as MSM, are likely...
Background Mycoplasma genitalium (Mg) is an emerging sexually transmitted pathogen among men who ...
Abstract Background: Mycoplasma genitalium (MG) is an emerging sexually transmitted pathogen and a c...
During 2016–2017, we tested asymptomatic men who have sex with men (MSM) in Melbourne, Australia, fo...
BACKGROUND Mycoplasma genitalium infection is a public health concern due to extensive antimicrob...
Abstract Background Antimicrobial resistance in Mycoplasma genitalium is rising globally with result...
During 2016-2017, we tested asymptomatic men who have sex with men (MSM) in Melbourne, Australia, fo...
BackgroundPre-exposure prophylaxis (PrEP) is an effective method for reducing HIV incidence among at...
Mycoplasma genitalium (MG) is a sexually transmitted bacterium in which macrolide resistance is rapi...
OBJECTIVES: Limited data on Mycoplasma genitalium infection has been reported among PrEP users. The ...
Objectives: Azithromycin treatment of Chlamydia trachomatis (CT) may not be adequate to treat concom...
BackgroundPre-exposure prophylaxis (PrEP) is an effective method for reducing HIV incidence among at...
ObjectivesMacrolide resistance in Mycoplasma genitalium is emerging globally. There is paucity of da...